DR Reddys Laboratories Limited Imatinib Export Data — India (DGFT 2022–2026)

Name: DR Reddys Laboratories Limited Imatinib Export Records India — #10 Exporter, 4 Shipments, $200.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Imatinib

India Pharmaceutical Trade Intelligence

$29.3M224 Suppliers119 CountriesHS 30049049

ExportsIndia → UNITED STATES24.3%India → BELGIUM12.4%

ImportsGERMANY → India$331.7M UNITED STATES → India$584.7K

#1 Supplier: CIPLA LIMITED #1 Buyer: H.ESSERS &

DR Reddys Laboratories Limited — Imatinib Exporter #10 | $200.0K Trade Value | TransData Nexus | TransData Nexus

DR Reddys Laboratories Limited — Imatinib Exporter Profile

Indian Pharmaceutical Exporter · #10 for Imatinib · $200.0K export value · DGFT Verified

DR Reddys Laboratories Limited is the #10 Indian exporter of Imatinib with $200.0K in export value and 4 verified shipments. DR Reddys Laboratories Limited holds a 0.7% market share in Imatinib exports across 3 countries. The company exports 37 pharmaceutical products worth $62.4M across 17 therapeutic categories.

DR Reddys Laboratories Limited — Imatinib Export Profile: Buyers & Destinations

DR Reddys Laboratories Limited Imatinib export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Imatinib?

Country	Value	Shipments	Share
UNITED STATES	$7.1M	156	34.3%
BELGIUM	$3.6M	145	17.6%
PAKISTAN	$2.6M	52	12.5%
MOROCCO	$1.6M	33	8.0%

Who Are the Top Buyers of Imatinib from India?

Buyer	Country	Value	Orders
AUROLOGISTICS LLC, (AUROBINDO PHARM	UNITED STATES	$1.5M	30
JS BANK LTD.	PAKISTAN	$850.0K	17
COOPER PHARMA	MOROCCO	$800.0K	16
HABIB BANK LIMITED	PAKISTAN	$750.0K	15
AUROBINDO PHARMA USA INC	UNITED STATES	$700.0K	14
AUROBINDO PHARMA USA., INC,	UNITED STATES	$650.0K	13
OOO"JODAS EXPOIM"	RUSSIA	$400.0K	8
H.ESSERS & ZONEN INTERNATIONAL TRAN	BELGIUM	$300.0K	6
MEDPRO PHARMACEUTICA (PTY) LTD	SOUTH AFRICA	$300.0K	6
OOO JODAS EXPOIM	RUSSIA	$200.0K	4

India's Imatinib is purchased by 456 buyers worldwide. The top buyer is AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES), followed by JS BANK LTD. and COOPER PHARMA.

How Does DR Reddys Laboratories Limited Compare to Nearest Imatinib Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	MSN LABORATORIES PRIVATE LIMITED	$219.5K	13	3	$16.9K
13	VEXXA LIFESCIENCES PVT. LTD.	$204.3K	57	2	$3.6K
10	DR REDDYS LABORATORIES LIMITED ★	$200.0K	4	3	$50.0K
14	SUN PHARMACEUTICAL INDUSTRIES LTD	$170.3K	4	1	$42.6K

DR Reddys Laboratories Limited ranks #10 among 224 Indian Imatinib exporters. Average shipment value of $50.0K compared to the market average of $82.5K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and VEXXA LIFESCIENCES PVT. LTD..

Which Indian Ports Ship Imatinib Exports?

Port	Shipments	% Share
SAHAR AIR	314	18.2%
SAHAR AIR CARGO ACC (INBOM4)	301	17.4%
DELHI AIR CARGO ACC (INDEL4)	235	13.6%
DELHI AIR	142	8.2%
Bombay Air	123	7.1%
HYDERABAD AIR	69	4.0%
HYDERABAD ACC (INHYD4)	61	3.5%
AHEMDABAD AIR	35	2.0%

Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Imatinib Exports

The global pharmaceutical export landscape has been significantly influenced by recent geopolitical events. The 2026 Strait of Hormuz crisis, initiated by military conflicts involving the United States, Israel, and Iran, led to the effective halt of shipping traffic through this critical maritime route, disrupting approximately 20% of the world's daily oil supply and causing a surge in global energy prices. (en.wikipedia.org) This disruption has had a cascading effect on shipping costs and insurance premiums, directly impacting Indian pharmaceutical exporters like Dr. Reddy's, which rely on these routes for timely delivery of products to key markets.

Simultaneously, the 2025–26 United States–India diplomatic and trade crisis, marked by the imposition of a 50% tariff on Indian exports by the U.S., has posed additional challenges. These tariffs have increased the cost of Indian pharmaceutical products in the U.S. market, potentially affecting the competitiveness of companies like Dr. Reddy's. (en.wikipedia.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. Dr. Reddy's has been proactive in adhering to these regulations, ensuring that its products meet the stringent safety and traceability standards mandated by the EU, thereby maintaining its market access and reputation.

DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Dr. Reddy's has demonstrated a commitment to quality by securing approvals from major regulatory bodies, including the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Medicines Agency (EMA). The company's recent Biologics License Application (BLA) submission for a proposed interchangeable biosimilar to Orencia® (abatacept) underscores its adherence to rigorous regulatory processes. (stockwatch.com)

However, the company has faced regulatory challenges, such as the tax audit decision from the Russian Federal Tax Service in January 2026, which reclassified certain marketing services as taxable, resulting in a penalty. (stocktitan.net) Such incidents highlight the complexities of operating in diverse regulatory environments and the importance of robust compliance frameworks.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Imatinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: DR Reddys Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 119+ countries, 456+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Imatinib

Imatinib

DR Reddys Laboratories Limited — Imatinib Exporter Profile

DR Reddys Laboratories Limited — Imatinib Export Profile: Buyers & Destinations

Where Does India Export Imatinib?

Who Are the Top Buyers of Imatinib from India?

What Is India's Total Imatinib Export Value and How Much Does DR Reddys Laboratories Limited Contribute?

What Is the Average Shipment Value for DR Reddys Laboratories Limited's Imatinib Exports?

How Does DR Reddys Laboratories Limited Compare to Other Indian Imatinib Exporters?

Regulatory Requirements: Exporting Imatinib to Key Markets

United States — FDA

How Does DR Reddys Laboratories Limited Compare to Nearest Imatinib Exporters?

Which Indian Ports Ship Imatinib Exports?

Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Imatinib Exports

DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards

About DR Reddys Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Imatinib Export Data from DR Reddys Laboratories Limited

Imatinib Stats

Company Overview

Top Products by DR Reddys Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source